REDWOOD CITY, Calif.,
July 24, 2017 /PRNewswire/
-- Nevro Corp. (NYSE: NVRO), a global medical device company
that is providing innovative evidence-based solutions for the
treatment of chronic pain, today announced that it will release
financial results for the second quarter of 2017 after market close
on Monday, August 7, 2017. Company
management will host a conference call beginning at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) on Monday, August 7, 2017.
Investors interested in listening to the conference call may do
so by dialing (877) 648-7976 for U.S. callers, or (617) 826-1698
for international callers (Conference ID: 52275180), or from the
webcast on the "Investors" section of the Company's website at
www.nevro.com/investors. Following the call, a replay will be
available on the Investor Events and Presentations webpage of the
Company's website.
About Nevro
Headquartered in Redwood City, California, Nevro is a global
medical device company focused on providing innovative products
that improve the quality of life of patients suffering from
debilitating chronic pain. Nevro has developed and commercialized
the Senza spinal cord stimulation (SCS) system, an evidence-based
neuromodulation platform for the treatment of chronic pain. The
Senza system is the only SCS system that delivers Nevro's
proprietary HF10 therapy. Senza, HF10, Nevro and the Nevro logo are
trademarks of Nevro.
Investor Relations Contact:
Nevro Investor
Relations
Katherine Bock
(650) 433-3247
ir@nevro.com
View original content with
multimedia:http://www.prnewswire.com/news-releases/nevro-to-report-operating-results-for-the-second-quarter-2017-300492941.html
SOURCE Nevro Corp.